Digital Transformation in Industry 4.0 Markets Surges with 19.4% CAGR Through 2030
Industry 4.0 Technologies Market
Dublin, Aug. 01, 2025 (GLOBE NEWSWIRE) -- The "Industry 4.0 Technologies: Global Markets Through 2030" report has been added to ResearchAndMarkets.com's offering.The global market for Industry 4.0 technologies was valued at $551.7 billion in 2024 and is estimated to increase from $655.2 billion in 2025 to reach $1.6 trillion by 2030, at a compound annual growth rate (CAGR) of 19.4% from 2025 through 2030.
Industry 4.0 represents the deep integration of intelligent digital technologies into manufacturing and broader industrial processes. This transformative approach encompasses interconnected technologies, including Industrial Internet of Things networks, AI, big data analytics, advanced robotics and comprehensive automation. The core objective of Industry 4.0 is to facilitate smart manufacturing and the development of intelligent factories, ultimately driving significant enhancements in productivity, efficiency and operational flexibility. Furthermore, it empowers more informed decision-making and enables greater customization throughout manufacturing and supply chain operations.Report ScopeThis report segments the market based on technology, end-user industry and geographical region. It provides an overview of the global Industry 4.0 technologies market and analyzes market trends. Using 2024 as the base year, the report provides estimated market data for the forecast period 2025 through 2030. The report covers the market for Industry 4.0 technologies with regard to the user base across different regions. It also highlights major trends and challenges that affect the market and the vendor landscape.The scope of the report includes the global market for Industry 4.0 technologies, such as big data and analytics, system integration (horizontal and vertical integration), cloud computing, augmented reality (AR) and virtual reality (VR), Industrial Internet of Things (IIoT), 3D printing, robotics, digital twins and cybersecurity, as they relate specifically to Industry 4.0.The report also examines the key trends and challenges driving the market and the companies operating within it. It analyzes patents and emerging technologies in the market, it surveys the competition among major companies, and it includes profiles of leading businesses in the market.The report includes:
59 data tables and 84 additional tables
An overview of the current and future global markets for industry 4.0 technologies
An analysis of the global market trends with market revenue data from 2024, estimates for 2025, forecasts for 2026, 2028, and projected CAGRs through 2030
Estimates of the size and revenue prospects of the global market, along with a market share analysis by technology, end use industry, and region
Facts and figures pertaining to market dynamics, technological advances, regulations, and the impact of macroeconomic factors
An analysis of patents, emerging trends and developments in the industry
Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
Company profiles of major players within the industry, including Amazon, Microsoft, Siemens, Cisco Systems Inc., and IBM Corp.
Key Attributes:
Report Attribute
Details
No. of Pages
221
Forecast Period
2025 - 2030
Estimated Market Value (USD) in 2025
$655.2 Billion
Forecasted Market Value (USD) by 2030
$1600 Billion
Compound Annual Growth Rate
19.4%
Regions Covered
Global
Key Topics Covered: Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Technological Advances and Applications
Market Dynamics and Growth Factors
Future Trends and Developments
Segmental Analysis
Regional Insights and Emerging Markets
Chapter 2 Market and Technology Overview
Technology Overview
Industry 4.0 Technologies and Applications
Current Market Overview
Big Data and Analytics
System Integration (Horizontal and Vertical Integration)
Cloud Computing
AR and VR
The Industrial Internet of Things
3D Printing
Robotics
Digital Twins
Cybersecurity
Future of Industry 4.0 Technologies
Macroeconomic Factors
Growing R&D Investments Driving Industry 4.0 Adoption
Economic Growth and Rising Consumer Spending
Geopolitical Conflict Shaping the Industry 4.0 Market
Tariff Impact on the Industry 4.0 Market
Aerospace and Defense
Automotive
Electrical and Electronics
Energy and Utilities
Chemicals
Pharmaceuticals
Conclusion
Porter's Five Forces Analysis
Competition in the Industry
Case Studies of Industry 4.0 Technologies
Chapter 3 Market Dynamics
Market Drivers
Growth of IoT Technology and Devices
Increased Government Funding for Robotics R&D
Increasing Labor Shortages
Real-Time Data Generated from Sensors and Other Smart Devices
Market Challenges
Safety and Security Concerns in Industry 4.0
Absence of Standardization in IoT Protocols for Industry 4.0
Interoperability Issues of Legacy Infrastructure and Communication Networks
Inadequate Information Technology Infrastructure and Connectivity Issues
Growing Number of Global Cyberattacks
Market Opportunities
Increasing Use of Cloud Deployments
3D-Printing Technologies Combined with Digital Twin Applications
The Ongoing Deployment of 5G Technology and the Emergence of 6G
Government Initiatives Supporting the Development of Industry 4.0 Technologies
Chapter 4 Emerging Technologies and Developments
Emerging Technologies and Developments
5G
6G
Edge and Fog Computing
Blockchain
Machine Learning
Cloud Robotics
Robotics as a Service
Digital Twins as a Service
Development in Augmented Reality and Virtual Reality Technology
Integration of Generative AI and Digital Twin Solutions
Cloud Encryption
Additive Manufacturing Technology as a Pillar of Industry 4.0
Microfluidic 3D Printing
AI-Powered Predictive Maintenance for 3D Printing
Patent Analysis
Company Share Patterns
Regional Patterns
Chapter 5 Market Segmentation Analysis
Industry 4.0 Technologies Market by Technology
Big Data and Analytics
System Integration (Horizontal and Vertical Integration)
Cloud Computing
Augmented Reality and Virtual Reality
Industrial Internet of Things
3D Printing
Robotics
Digital Twins
Cybersecurity
Industry 4.0 Technologies Market by End-use Industry
Aerospace and Defense
Automotive
Electrical and Electronics
Energy and Utilities
Chemicals
Pharmaceuticals
Others
Industry 4.0 Technologies Market by Region
Chapter 6 Competitive Intelligence
Market Ecosystem
Devices and Hardware
Software and Applications
Professional Services
Top Companies in the Industry 4.0 Technologies Market
Amazon
Microsoft Corp.
Siemens
Cisco Systems Inc.
IBM
Oracle
Strategic Analysis
Agreements, Collaborations and Partnerships
Mergers and Acquisitions
Investments and Expansions
Company Profiles
3D Systems Inc.
ABB
Accenture
Alphabet Inc. (Google Inc.)
Amazon.Com Inc.
Autodesk Inc.
Bosch Rexroth AG
Cisco Systems Inc.
Eos GmbH
GE Vernova
IBM Corp.
Intel Corp.
Materialise
Microsoft
Oracle
Rockwell Automation
Siemens
Sony Group Corp.
Stratasys
For more information about this report visit https://www.researchandmarkets.com/r/gbckdu
About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
Industry 4.0 Technologies Market
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 minutes ago
- Yahoo
Pharma CEOs downplay impact of tariffs amid rising cost concerns
Despite analyst warnings of heightened financial risk, pharma CEOs across the US and Europe remain confident that the latest US-EU trade deal and associated tariffs will have limited impact. As per a new deal between the two global economic powerhouses, the EU will pay the US a tariff rate of 15% for pharmaceuticals. Medicines are the largest European exports to the US by value, and the EU accounts for approximately 60% of all pharmaceutical imports to the US. Top-selling drugs such as AbbVie's Humira (adalimumab), MSD's Keytruda (pembrolizumab), and Novo Nordisk's Ozempic (semaglutide), for example, are manufactured in Europe and sent to the US, representing billion-dollar markets. Analysts from GlobalData's Pharma Strategic Intelligence team say that: 'Companies manufacturing pharmaceutical products in Europe will need to anticipate financial exposure when planning launches in the US due to the unfavourable gross to net dynamics, weakened pricing leverage with US payers, and slower commercial uptake as insurers reassess cost effectiveness due to the tariffs.' US President Donald Trump has had a sharp focus on the pharma industry since assuming office. Analysts predict that adding duties to incoming goods will likely elevate costs across the pharmaceutical value chain, ultimately raising drug prices for patients. The policies make for interesting analysis when combined with his desire to cut prescription prices in the country. Diederik Stadig, sector economist for TMT & healthcare at ING, wrote in a July note: 'A tariff would hurt consumers most of all, as they would feel the inflationary effect of tariffs directly when paying for prescriptions.' The European Federation of Pharmaceutical Industries and Associations (EFPIA), for example, has maintained that tariffs on medicines are ineffective. The group says such policies only hinder patient access to medicines. GlobalData also forecasts disruptions to launch planning, particularly late-stage assets with EU-based manufacturing and production planned for entry into the US. R&D budgets of pharmaceutical companies are already under pressure and the firefighting of tariffs could place additional strain on resources. CEOs signal resilience CEOs of big pharma companies, however, are maintaining a brave face despite the projected headwinds. The UK-EU trade deal announcement arrived in the middle of the pharma industry's Q2 reporting period, where execs were pressed on financial outlooks. In a Q2 earnings call, AbbVie's CEO Rob Michael said the US company is 'fairly insulated' from any tariff-related impacts in 2025, though caveated that the company would not speculate on the longer-term consequences. AstraZeneca shared the same sentiment. CEO Pascal Soriot said the British-Swedish drugmaker is 'almost self-sufficient in terms of supply,' adding that 'tariffs is not an issue that is really affecting us very much.' However, AstraZeneca is on a long list of pharma companies transferring manufacturing to the US. This includes a $4bn investment to build a new manufacturing plant in Virginia. Sanofi has outlaid $20bn to bolster US manufacturing through 2030 and Roche unveiled a similar $50bn investment strategy, to name just a couple. The team at GlobalData added: 'Ultimately, the recent US-EU trade deal has increased the level of uncertainty within the pharmaceutical industry, raising concerns on the potential of tariffs increasing past 15% in the future. 'While the full impact will take time to unfold, it will be interesting to see the adoption of different strategies on how the pharmaceutical industry looks to balance innovation, and ensuring patient access, while managing the pressures of tariffs as they unfold into a certain reality.' A critical part of the industry's future also relies on the outcome of the US government's Section 232 investigation into the drug sector. The probe, which Trump initiated to evaluate the role of medicine imports on national security, could result in further tariffs being imposed. MSD CEO Rob Davis said in the company's Q2 earnings call: 'We need to see more clarity both from the administration and just overall as to how exactly [the 15% tariff] is going to play out. It's still not clear exactly how this relates relative to the February investigation and the timing of whether these apply now or will be phased in until there's further guidance.' AbbVie's Michael said: 'We're having constructive discussions with the administration on sectoral tariffs. Clearly, the best way to motivate that is through tax incentives as well as a trade agenda that prioritises innovation. We're well positioned as a company, but we're not going to be able to really give you any details until we understand the outcome of the 232 investigation.' Navigate the shifting tariff landscape with real-time data and market-leading analysis. Request a free demo for GlobalData's Strategic Intelligence . "Pharma CEOs downplay impact of tariffs amid rising cost concerns" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Yahoo
8 minutes ago
- Yahoo
JPMorgan drops 3-word verdict on Amazon stock post-earnings
JPMorgan drops 3-word verdict on Amazon stock post-earnings originally appeared on TheStreet. Amazon () posted a superb Q2 on paper, but the market was mostly unfazed. Shares pulled back sharply, with investors fixating on Amazon Web Services (AWS) relatively lagging in growth. However, in that cloud of concern (no pun intended), JPMorgan sees an opening, not noise. 💵💰💰💵 Veteran Analyst Doug Anmuth's call effectively cuts through the volatility, while putting fresh focus on how Wall Street's top desks are interpreting Amazon's long-term AI and infrastructure story. Amazon's big AI bet tests investor patience Amazon's Q2 results showed a clear contrast in booming top-line expansion, massive investment on one side, and investor unease on the other. Overall sales jumped a superb 13% amounting to $167.7 billion, beating estimates by an eye-popping $5.60 net income surged, with a $1.68 EPS, blowing past estimates by 36 cents. However, all eyes were on AWS sales, which were relatively uninspiring. AWS sales grew 17.5% to $30.9 billion, but remarkably lagged the headline-grabbing growth at competitors. Putting things in perspective, Microsoft Azure posted a 39% jump, while Google Cloud surged 32%, reinforcing fears that AWS may be losing ground in the AI cloud race. Margins told a similar story. AWS operating margin fell sharply to 32.9%, down from 39.5% the prior quarter. Management attributed the squeeze to its aggressive GenAI investments and infrastructure hiccups, particularly with power, chip supply, and server yields. What turned heads, though, was the spending. Amazon's capital expenditures came in at a record $31.4 billion, up close to 90% year-over-year. That's a remarkably high number, especially with management calling it 'reasonably representative' of what's to come in the back half of the year. However, the goal at this point is clear, and it involves scaling AWS's infrastructure quick enough to support AI ambitions and relieve capacity strain. Wall Street wasn't sold, with concerns centering around AWS's slower growth, thinner margins, and unclear near-term return on the hefty capex. Still, CEO Andy Jassy defended the strategy. He emphasized that Amazon is still in the early innings of its powerful multi-year AI journey and that capacity constraints will ease as new infrastructure comes online. JPMorgan's three-word response on Amazon stock: Buy the pullback As previously mentioned, Amazon may have delivered on paper, but the market didn't see it that way. Amazon stock tanked over 8% on Aug. 1, but it clawed back some of those losses pre-market Aug. 4. Still, the initial drop raises some major questions. Nevertheless, one top voice on the Street isn't analyst Doug Anmuth at JPMorgan feels the dip is exactly when investors should move in. He feels investors should 'Buy the pullback,' backing up his Buy rating on Amazon stock, while boosting his price target from $255 to $265, implying a superb upside of 23% from current levels. So what triggered the drop? According to Anmuth, the culprit was AWS. While AWS revenue jumped 17.5% year-over-year to $30.9 billion, it underwhelmed investors who expected more, especially considering the backdrop of AI-fueled cloud expansion. That's not all. Amazon also reported a record $31.4 billion in capex, which only made matters worse in compounding the pressure on AWS to deliver even bigger growth numbers. Still, the Street isn't backing off. Analysts at Citi also bumped their price target on the stock to $270, noting Amazon's higher spending reflects healthy demand and efforts to fix infrastructure constraints in the cloud. However, it's important to consider that growth lagged peers, and management didn't exactly calm concerns around the AI opportunity. Despite that, the Wall Street punditry believes the selloff doesn't match the broader story. And for JPMorgan, this is the kind of dip worth loading up on. AWS: Amazon's profit engine and AI powerhouse AWS is far from purely a segment; it's arguably the profit core and strategic anchor for the entire business. It's responsible for close to 60% of Amazon's operating income, with AWS running at an annualized sales pace above $123 billion. That scale gives it the profile of a standalone cloud giant, one that underpins the bulk of Amazon's enterprise Andy Jassy has reiterated AWS's incredible competitive moat, noting it's still 'meaningfully larger' than its next-closest rival. Recent data supports that lead. Per the most recent reports, AWS commands roughly 31% to 32% of the global cloud infrastructure market, followed closely by Microsoft Azure with roughly 22.5% to 24%, and Google Cloud at 10% to 12%. Other estimates tend to vary based on methodology, but generally confirm AWS's position at the top, with competitors trailing by a hefty margin. AI is rapidly deepening that role. AWS is investing a ton of money in generative and agentic AI, in serving external clients through the Generative AI Innovation Center. Another key differentiator for AWS is that it effectively originates from Amazon's internal infrastructure needs before commercialization. It comes with embedded efficiency and noteworthy cash-flow sustainability, making it more than a cost center, powering internal tools like Amazon Personalize. That synergy creates a robust loop where AI sharpens retail engagement and fuels more demand for compute. More News: Amazon's quiet pricing twist on tariffs stuns shoppersBank of America flags 3 breakout stocks to watch ahead of earnings Margins may have compressed recently on the back of AWS building its custom infrastructure, including Trainium chips, but those bets are about long-term dominance. JPMorgan drops 3-word verdict on Amazon stock post-earnings first appeared on TheStreet on Aug 4, 2025 This story was originally reported by TheStreet on Aug 4, 2025, where it first appeared.
CNN
10 minutes ago
- CNN
Ukraine is now Trump's war
Donald Trump Russia War in UkraineFacebookTweetLink Follow Vladimir Putin started it. Joe Biden didn't stop it. But, no matter his efforts to the contrary, this is the week in which Russia's invasion of Ukraine becomes US President Donald Trump's war. The most powerful office in the world doesn't always invite choices. Trump is mandated to address the biggest conflict in Europe since World War II because the United States was involved, under his predecessor, as Ukraine's key ally and sponsor. Trump could have dropped the war entirely. But instead, he chose to impose the force of his personality, initially through the idea he could end it in 24 hours, or a revised deadline of 100 days. Then he tried to navigate its personalities, cozying up to the Russian president initially, echoing his narratives and then berating Ukrainian President Volodymyr Zelensky publicly in the Oval Office. He hit his NATO allies hard, demanding they pay more for Europe's defense, which they did. And then the hard slog of diplomacy sputtered into gear, ultimately yielding very little. But it is in the last fortnight that Trump's decisions – and realizations – have turned this into a problem he now owns. He has seen Putin does not want peace. He has seen Ukraine urgently needs arms, and he tried to help, albeit in a lackluster way. He made the remarkable choice of responding to the usually dismissed nuclear saber-rattling of former Russian President Dmitry Medvedev, with harder nuclear threats about positioning US nuclear submarines closer to Russia. The US went from pausing military aid to Ukraine to threatening nuclear force against Russia in less than a month. As this week ends, with Trump's shortened deadline for a peace deal coming into view, he must make perhaps the most consequential decision of the conflict yet. Does he impose penalties – secondary tariffs against Russia's energy customers – that really hurt? Does he accept the US and its allies might need to endure a little pain economically, to inflict pain? Imposing serious secondary sanctions on India and China could roil the global energy market. Trump posted Monday he would be increasing tariffs on India because it was selling Russian crude on at a profit, and he didn't 'care how many people are being killed by the Russian War Machine,' although he did not provide details as to the new measures. India has not made it publicly clear if it intends to stop buying Russian energy products. China is utterly dependent on Russian oil and gas and simply cannot afford to stop buying it. CNN's Nick Paton Walsh describes the riveting escape plan hatched by Ukrainian forces to save the life of an injured soldier pinned down by Russian attacks. To avoid another a 'TACO' moment – short for Trump Always Chickens Out – Trump will have to cause some discomfort and will likely feel some back. Or he can look for an off-ramp, if one is offered to his special envoy Steve Witkoff in an expected Moscow visit this week. Trump could perhaps accept a bilateral meeting with Putin as a sign of progress toward peace. But even this backing down would still mean he has left his indelible imprint on the war – that, in the words of former US Secretary of State Colin Powell regarding Iraq, if the United States breaks it, they own it. Trump cannot have it both ways. It is in his nature to seek to be the fulcrum of all decisions, and the lightning rod of attention, on any given issue. Every turning point so far has been based around his personal choice and fancy. And with this comes a key lesson of the American presidency. Trump does not get to choose which problems are his, and which he can ignore. MAGA's America First platform may be about reducing Washington's global footprint, but it doesn't permit Trump to own solely his successes – and not his failures. Unless Trump reduces the footprint of American power globally to zero – incompatible with a presidential personality compelled to 'do' and agitate – there will always be some problems that are America's. He says he wants wars to stop. But that is not enough in itself. The wars have not all complied. Former US President Barack Obama inherited wars in both Iraq and Afghanistan. He ducked fast out of the former, and doubled down with a surge in the latter, which did not work. Afghanistan became Obama's war, even though it was a mess he had inherited. Trump in turn was passed that mess, and he handed his quick fix to Biden to execute, in the chaotic collapse of August 2021, widely paraded by Republicans as a Democrat failing. Trump faces the same problem of inheriting a crisis. He cannot wish or cajole the conflict to an end. The very battlefield deaths he mourns have sewn damage and grief afar, turning this into an existential war of survival for the Kremlin, and for the soul of Ukrainian society. Ukrainians want to live in peace, without nightly air raid sirens. Putin does not want peace, and instead his most recent maximalist demands amount to something tantamount to Ukrainian surrender. Ultimately, it is reflection of a harsh reality that this should be seen as Trump's war. It is the defining conflict of his presidency and of the post-9/11 era. Its outcome defines European security and Chinese belligerence over the next decade. China understands that and needs Russia to win. Europe understands that, and is arming itself so Russia does not see opportunity in the bloc's weakness. Whether Trump understands this and accepts discomforting, strident decisions with the consequences that follow, we will learn in the week ahead.
